1-(1H-benzo[d]imidazol-6-yl)-8-phenyl-1H-imidazo-[4,5-c][1,7]naphthyridine

ID: ALA3919207

PubChem CID: 134139857

Max Phase: Preclinical

Molecular Formula: C22H14N6

Molecular Weight: 362.40

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  c1ccc(-c2cc3c(cn2)ncc2ncn(-c4ccc5nc[nH]c5c4)c23)cc1

Standard InChI:  InChI=1S/C22H14N6/c1-2-4-14(5-3-1)18-9-16-20(10-23-18)24-11-21-22(16)28(13-27-21)15-6-7-17-19(8-15)26-12-25-17/h1-13H,(H,25,26)

Standard InChI Key:  KLCTWPGEFCWMHD-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 33  0  0  0  0  0  0  0  0999 V2000
   11.6951  -16.3644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4003  -15.9556    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.1089  -16.3608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1096  -17.1798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8182  -17.5869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5264  -17.1761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5217  -16.3540    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.8126  -15.9506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4020  -17.5929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6926  -17.1808    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0814  -17.7281    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.4131  -18.4786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2292  -18.3950    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.7731  -19.0012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5169  -19.7783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1154  -19.4379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5693  -18.8328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8697  -20.2211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0603  -20.3896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9704  -21.2114    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.7243  -21.5509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2800  -20.9388    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.2399  -17.5791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2427  -18.3983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9553  -18.8013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6620  -18.3848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6516  -17.5613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9385  -17.1621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 10  2  0
  9  4  2  0
  3  2  2  0
  2  1  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13  9  1  0
 14 15  2  0
 15 19  1  0
 18 16  1  0
 16 17  2  0
 17 14  1  0
 13 14  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 22 18  1  0
  6 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3919207

    ---

Associated Targets(Human)

MAP3K8 Tchem Mitogen-activated protein kinase kinase kinase 8 (459 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 362.40Molecular Weight (Monoisotopic): 362.1280AlogP: 4.51#Rotatable Bonds: 2
Polar Surface Area: 72.28Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.22CX Basic pKa: 6.31CX LogP: 3.40CX LogD: 3.37
Aromatic Rings: 6Heavy Atoms: 28QED Weighted: 0.49Np Likeness Score: -1.08

References

1. Glatthar R, Stojanovic A, Troxler T, Mattes H, Möbitz H, Beerli R, Blanz J, Gassmann E, Drückes P, Fendrich G, Gutmann S, Martiny-Baron G, Spence F, Hornfeld J, Peel JE, Sparrer H..  (2016)  Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase Inhibitors.,  59  (16): [PMID:27502541] [10.1021/acs.jmedchem.6b00598]

Source